Player FMアプリでオフラインにしPlayer FMう!
Feb 16 2024 This Week in Cardiology
Manage episode 401342732 series 2794872
An update in trial interpretation, CI, and P-values; percutaneous tricuspid Interventions; and news on HDL and humility in Medicine are the topics John Mandrola, MD, covers in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Evidence of Absence Is not Absence of Evidence
Feb 09, 2024 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/1000101
- ARCADIA Trial https://jamanetwork.com/journals/jama/fullarticle/2814933
- FOURIER Trial https://www.nejm.org/doi/full/10.1056/nejmoa1615664
- Sample Size Calculator https://clincalc.com/stats/samplesize.aspx
II. Tricuspid Valve Interventions
FDA OKs First Transcatheter Tricuspid Valve Replacement
FDA Panel in Favor of TriClip for Tricuspid Regurgitation
https://www.medscape.com/viewarticle/fda-panel-favor-triclip-tricuspid-regurgitation-2024a100037n
- Cardiothoracic Surgical Trials Network Study https://www.nejm.org/doi/full/10.1056/NEJMoa2115961
- TRILUMINATE https://www.nejm.org/doi/full/10.1056/NEJMoa2300525
- KAUL Tweet on ATTR Cardiomyopathy https://twitter.com/kaulcsmc/status/1753552603534016622?s=20
- APOLLO B trial https://www.nejm.org/doi/full/10.1056/NEJMoa2300757
- Al-Lamee Tweet on Sham Controls https://x.com/rallamee/status/1758236588570562736
III. HDL Cholesterol
- Rationale paper — AEGIS https://doi.org/10.1016/j.ahj.2020.10.052
- Press Release AEGIS II https://www.prnewswire.com/news-releases/csl-announces-top-line-results-from-the-phase-3-aegis-ii-trial-evaluating-the-efficacy-and-safety-of-csl112-apolipoprotein-a-i-human-302059156.html
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
349 つのエピソード
Manage episode 401342732 series 2794872
An update in trial interpretation, CI, and P-values; percutaneous tricuspid Interventions; and news on HDL and humility in Medicine are the topics John Mandrola, MD, covers in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Evidence of Absence Is not Absence of Evidence
Feb 09, 2024 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/1000101
- ARCADIA Trial https://jamanetwork.com/journals/jama/fullarticle/2814933
- FOURIER Trial https://www.nejm.org/doi/full/10.1056/nejmoa1615664
- Sample Size Calculator https://clincalc.com/stats/samplesize.aspx
II. Tricuspid Valve Interventions
FDA OKs First Transcatheter Tricuspid Valve Replacement
FDA Panel in Favor of TriClip for Tricuspid Regurgitation
https://www.medscape.com/viewarticle/fda-panel-favor-triclip-tricuspid-regurgitation-2024a100037n
- Cardiothoracic Surgical Trials Network Study https://www.nejm.org/doi/full/10.1056/NEJMoa2115961
- TRILUMINATE https://www.nejm.org/doi/full/10.1056/NEJMoa2300525
- KAUL Tweet on ATTR Cardiomyopathy https://twitter.com/kaulcsmc/status/1753552603534016622?s=20
- APOLLO B trial https://www.nejm.org/doi/full/10.1056/NEJMoa2300757
- Al-Lamee Tweet on Sham Controls https://x.com/rallamee/status/1758236588570562736
III. HDL Cholesterol
- Rationale paper — AEGIS https://doi.org/10.1016/j.ahj.2020.10.052
- Press Release AEGIS II https://www.prnewswire.com/news-releases/csl-announces-top-line-results-from-the-phase-3-aegis-ii-trial-evaluating-the-efficacy-and-safety-of-csl112-apolipoprotein-a-i-human-302059156.html
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
349 つのエピソード
すべてのエピソード
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。